NFE2L2 and neoplasm: Consequently, expression of NFE2L2, GPX4 and other anti-ferroptosis genes was upregulated in RMC cells from the MVAC-treated tumour compared to TAL cells, whereas many pro-ferroptosis genes were higher expressed in TAL cells (Fig. 5b).